leuprolide

(redirected from Viadur)
Also found in: Medical.

leu·pro·lide

 (lo͞o′prō-līd′)
n.
A drug that is a synthetic polypeptide analog of naturally occurring gonadotropin-releasing hormone, C29H84N16O12, used in its acetate form to treat advanced prostate cancer.

Mentioned in ?
References in periodicals archive ?
GnRHs, which include Eligard, Lupron, Synarel, Trelstar, Vantas, Viadur, Zoladex and several generic options, block testosterone production by the testicles, with the result that almost no testosterone circulates in the body.
Medications in the GnRH class are marketed under the brand names Eligard, Lupron, Synarel, Trelstar, Vantas, Viadur, and Zoladex.
The FDA has not made any conclusions about whether diabetes or these cardiovascular diseases are caused by treatment with these drugs, which are available in generic formulations and as brand-name products (Lupron, Eligard, Synarel, Trelstar, Vantas, Viadur, and Zoladex).
and leuprolide acetate, sold as Lupron, Eligard, Viadur and as generics.
Some of the products developed through these off-balance sheet arrangements include Ditropan XL for over active bladder, Concerta for hyperactivity, and the cancer treatments known as Viadur and Doxil.
Martell has served concurrently as Assistant Clinical Professor of Oncology at Yale University School of Medicine and Staff Physician at the Veterans Affairs hospital, and he also worked at Bayer Pharmaceutical Division, where he oversaw the Phase I and Phase II studies for BAY 43-9006 (Sorafenib, a RAF Kinase/VEGF/PDGF inhibitor) and the post-marketing clinical development of Viadur.